How to Choose a Peptide Synthesizer

CSBio Peptide Synthesizer Selection Guide

Choosing an automated peptide synthesizer starts with understanding the work you need the system to perform. A discovery lab making small research quantities has very different requirements than a process development group preparing for scale-up, a clinical manufacturing team operating under GMP expectations, or a commercial facility producing peptide API at large scale.

CSBio manufactures both peptide synthesizers and peptides, from milligram research quantities through kilogram-scale production. That experience is reflected in a product line that spans compact benchtop systems, flexible research and process development platforms, pilot-scale systems, and custom commercial-scale peptide synthesizers.

When selecting a system, the most important factors are scale and reaction vessel size, throughput, chemistry flexibility, mixing and heating technology, software continuity, GMP readiness, and day-to-day operational logistics.

Quick reference: recommended CSBio systems by need

This table is a starting point for matching your application to the right CSBio peptide synthesizer platform.

1. Start with the amount of peptide you need to make

Reaction vessel size is one of the most important practical differences between peptide synthesizers. It determines the working synthesis scale, the amount of resin that can be used, the volume of solvent and reagents required, and the approximate quantity of crude peptide that can be produced per batch.

For research work, users may only need ten to hundreds of milligrams of purified peptide. For process development, the goal may be to generate enough material to evaluate chemistry, purification strategy, impurity profiles, and scale-up behavior. For clinical or commercial manufacturing, the goal is focused towards reproducible production, high yield and purity, low waste, documentation, facility integration, and long-term support.

Peptide output depends on resin substitution, peptide length, molecular weight, sequence difficulty, loading, coupling strategy, and purification yield; identifying these factors can help establish the reaction vessel size required.

2. Confirm what “fully automated” actually means

A fully automated peptide synthesizer should automate the complete synthesis cycle for each amino acid, including deprotection, washing, coupling, and additional washes. For research-scale systems, this usually means the user can start a method and return to a completed peptide without manual intervention between amino acids.

This is important as some instruments from other manufacturers described as peptide synthesizers only automate part of the process, such as heating or the coupling step. In a typical SPPS cycle, the coupling step is only one part of the workflow. Manual deprotection, washing, solvent handling, or amino acid charging between steps can add significant labor and variability.

At larger scale, the level of automation that CSBio incorporates into our peptide synthesizers will vary based on the end user's workflow. A 1000 L commercial system may fully automate each synthesis cycle while still requiring operator intervention between couplings for material handling, charging, sampling, or process checks. This generally makes sense given an operator will be available during the majority of the synthesis, the batch cost is significant, and cycle times will be much longer. Mid-scale and pilot-scale systems will generally still be fully automated to complete a peptide without manual intervention between amino acid cycles like the research scale systems, while pilot and smaller commercial systems will fall between these two operating models depending on configuration.

3. Start with the application and day-to-day workflow

The use case is a major input in deciding on a peptide synthesizer. Users who simply want target peptides at small research scale should choose differently than users who need to develop chemistry, scale a process, support clinical production, or operate a commercial peptide manufacturing facility.

The best peptide synthesizer is the one with the right technical capability that also aligns with how the laboratory or manufacturing site will actually operate. A compact research lab may care most about quick setup and simple operation, while a process development or manufacturing site may care more about chemistry flexibility, solvent handling, operator workflow, batch documentation, and facility integration.

For users who want a simple research system, the CSBio II is designed to be compact and quick to set up. It is intended for users who want to make peptides at smaller scale using established protocols rather than writing extensive custom methods.

For users who need to change chemistry, run difficult sequences, test alternate coupling strategies, or prepare for scale-up, the CS136X provides more control and flexibility. It includes 9 solvent reservoir positions, supports custom programming of each step in the synthesis cycle, and can be configured with many options for users who need to evaluate coupling chemistry, capping, selective deprotection, alternate wash strategies, temperature control, or other process parameters.

For high-throughput research groups, the CS136M is designed for making many small-scale peptides under the same protocol conditions. This is most useful when the lab is trying to produce many peptides per month rather than optimize a process for one peptide.

The CS536X is similar in philosophy to the CS136X, but larger. It is better suited for process development that is intended to support larger pilot or commercial-scale batches. Users can evaluate chemistry, wash strategies, solvent use, PAT tools, temperature control, and other process parameters at a scale that is more representative of future manufacturing.

The CS936S provides reaction vessels in the 2 L to 10 L range, making it even more representative for very large-scale commercial batches. It also allows larger single-batch runs than the CS536X. In a standard configuration, the CS936S has 12 amino acid reservoir positions, so users should consider sequence length, amino acid charging workflow, and whether their process can run fully unattended through the required number of cycles or should include planned operator intervention or custom reservoir options.

For process development, users should also think about what will eventually matter at larger scale. Process analytical technology, solvent-saving strategies, solvent recycling, solvent pre-conditioning, and controlled wash optimization can be developed at pilot scale before being incorporated into larger-scale synthesis.

At commercial scale, users will need to consider production strategy. For a facility making many different peptides, two 500 L synthesizers may be a better fit than one 1000 L synthesizer because it provides more scheduling flexibility and allows different campaigns to be managed in parallel. For a single high-volume peptide, it may be better to run one 500 L batch than to buy a 50 L system and repeat the same GMP work ten times to reach the desired production quantity.

4. Mixing and heating technology

Efficient mixing and precise temperature control are important for coupling efficiency, crude purity, synthesis speed, and reproducibility, especially with longer or more difficult peptide sequences.

CSBio systems use scalable mixing and conductive heating technologies that can be applied from research-scale systems through large-scale production. This is important because a heating or mixing approach that works only at very small scale may not translate well into pilot or commercial manufacturing.

• CSBio II: patented double-chamber nitrogen bubbling for compact research-scale synthesis.
• CS136X and CS136M: patented 180° inversion mixing with nitrogen bubbling for strong resin-to-solvent contact.
• CS536X, CS936S, CS936, and CS936X: overhead stirring combined with nitrogen bubbling for uniform mixing at larger volumes.

CSBio uses conductive heating through jacketed reaction vessels, and heat exchangers for pre-heating. A software-controlled heated or chilled circulator can control the vessel temperature during synthesis. Conductive heating is reproducible and scalable from research systems to large commercial systems, avoiding the scale-up limitations associated with microwave or induction heating approaches.

For more detail, see CSBio’s resources on microwave vs. conduction heating and conduction preheating in SPPS.

5. Software continuity and scale-up

Software becomes increasingly important as users move from research synthesis into process development, clinical production, and commercial manufacturing. A method that is developed in one software environment and then has to be recreated in a different platform can add time, risk, and training burden.

CSBio systems use the CSBio CSPEPM Peptide Synthesis software platform across research, pilot, and commercial-scale peptide synthesizers. This gives users a consistent workflow as they move from small-scale method development to larger-scale production. Protocols still need to be evaluated, scaled, and validated appropriately, but users can easily translate and scale up without having to learn an entirely different software environment at each stage.

6. GMP readiness, customization, and process integration

All CSBio systems can be configured for GMP manufacturing, with the exception of the CSBio II, which is designed as a compact research-scale, plug-and-play system.

For GMP applications include 21 CFR Part 11 compliant software, documentation packages, Design Qualification, IQ/OQ support, Factory Acceptance Testing, and materials of construction.

Commercial-scale systems are configured specifically based on the end user's facility and process. CSBio offers standard options across its system platforms, custom options on standard systems, and fully custom build-to-order peptide synthesizers.

Available options can include process analytical technologies such as UV monitoring, refractive index, Raman, pH monitoring, solvent pre-conditioning, solvent recycling, flow through technology, percolation washing, various sensors, and hazardous-area design considerations such as ATEX or NEC requirements when applicable.

7. Facility setup and commercial scale strategy

At commercial scale, selecting a peptide synthesizer is partly an equipment decision and partly a facility and workflow decision. The right system size depends on the target batch output, number of peptide programs, operator workflow, solvent handling plan, and how the process will be supported over many batches.

Users should evaluate whether a chemistry has already been established, and how various solvents are received and delivered to the system, as well as how waste is managed. The same is true for amino acid and reagent charging, resin handling, sampling, and transfer of crude peptide after synthesis.

For a single high-volume product, it is usually better to choose a system that can produce the desired batch quantity without excessive repeated runs. A 50 L synthesizer may be too small if the production target requires ten separate batches to achieve what could be produced in one larger run. For a facility making many different peptide products, multiple medium-sized systems may provide more scheduling flexibility than one very large system.

These commercial-scale decisions should be made together with facility layout, utilities, solvent and waste infrastructure, hazardous area classification, documentation expectations, and operator workflow. CSBio commercial systems are all tailored to the site and process.

8. Model-to-model comparisons

CSBio II vs. CS136X: compact entry point vs. flexible workhorse

The CSBio II is best for users who want a compact, plug-and-play research system for smaller-scale peptide synthesis. It is designed for users who want to make peptides without adjusting for specific synthesis chemistry. The system includes protocols on the instrument, allowing the user to select a protocol and begin synthesis with minimal setup. The CSBio II is a strong fit for users making smaller quantities of peptides, in the 0.05 to 0.1 mmol range with it's interchangable 6 mL or 15 mL reaction vessels.

The CS136X is the more flexible research and process development platform. It supports interchangeable reaction vessels from 20 mL to 200 mL, 9 solvent reservoir positions, flexible chemistry, custom protocol development, various system options, and up to 3 reaction vessels. It is better suited for users who want to adjust coupling chemistry, optimize methods, synthesize difficult or long sequences, evaluate process conditions, or begin moving toward small-batch GMP manufacturing.

CS136X vs. CS136M: flexible development vs. high-throughput parallel synthesis

The CS136X is the right choice when flexibility matters. It can support process development, protocol optimization, different chemistries, and scale-up work. It can also be configured for multiple reaction vessels when users need more capacity while preserving synthesis protocol flexibility.

The CS136M is designed for high-throughput parallel research synthesis. It is the better fit for laboratories making many peptides per month, such as 50 or more different peptides around the 0.2 mmol scale range. The CS136M is not typically the best choice for users focused on process development, scale-up, or frequent changes to chemistry and protocols across different peptides.

CS536X vs. CS936S: process development vs. larger pilot production

The CS536X is well suited for process development and scale-up work. It provides a bridge between research-scale development and larger pilot production, while retaining configurable process-development options. It is the better choice when users want to test chemistry, process parameters, PAT options, solvent-saving strategies, and other development variables before moving to larger manufacturing.

The CS936S is designed for larger pilot-scale production and clinical-stage work. It is a 2 L to 10 L platform intended for robust pilot scale peptide synthesis and larger batch output. Because the scale is closer to commercial equipment, it can be a better representative platform for users preparing for very large-scale production.

Users who are still developing the process generally start with more flexibility, such as the CS536X. Users who have a more defined process and need larger single-batch output will generally be better aligned with the CS936S or a commercial CS936/CS936X configuration.

Need help selecting a system? Contact CSBio at instrument@csbio.com, schedule a call to discuss your peptide synthesizer needs, or call +1 650 525 6200.